Skip to main content
Erschienen in: Journal of Mammary Gland Biology and Neoplasia 1/2024

Open Access 01.12.2024 | Editorial

The Lymphatic System in Mammary Gland Biology and Breast Cancer

verfasst von: Traci R. Lyons, Esta Sterneck

Erschienen in: Journal of Mammary Gland Biology and Neoplasia | Ausgabe 1/2024

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The proper functioning of an organism and any organ within it requires the concerted and harmonic cooperation of all its diverse components. One of these essential parts is the lymphatic vasculature, which has for the longest time lingered in the shadow of its more visible counterpart – the blood vasculature. However, recent substantial developments and improvements in molecular approaches and imaging tools are beginning to shed light onto the details of anatomy and functions of the lymphatic system in health and disease, especially cancer [1]. Tumor development and progression are intricately connected with the functions of the lymphatics as is their contribution to patient treatment and recovery [2].
In this special issue of The Journal of Mammary Gland Biology and Neoplasia we have collected contributions on the involvement of the lymphatic system in normal mammary gland physiology and breast cancer metastasis as well as cancer patient recovery. There are four articles which span the range from clinical implications of axillary lymph node dissection (Kinney et al. [3]) to the impact of lifestyle factors such as diet and duration of lactation (Balema et al. [4]), to basic science implicating lymphatic secretions in attraction of breast cancer cells (Giotopoulou et al. [5]) and finally a comprehensive literature review of lymphatic remodeling that occurs during mammary development and breast cancer progression (Dahms and Lyons [6]).
As described in the article by Dahms and Lyons, the lymphatic vasculature is remodeled during each stage of mammary gland development including puberty, pregnancy, and involution. These processes have been characterized through both imaging as well as histological analyses. Additionally, the contribution of immune-suppressive macrophages is reviewed and several signaling axes that are in common between normal development and cancer progression overall suggesting that the similarities between mammary lymphatics and tumor associated lymphatics could be exploited to further understand and/or prevent breast cancer metastasis.
In support of this, the manuscript by Fuxe and colleagues identifies mechanisms by which TGFβ stimulates the migration of mesenchymal breast tumor cells to the lymphatics, which may contribute to lymphatic metastasis. TGFβ is a well-known mediator of mammary gland development. The study by Giotopoulou et al. identifies chemokines that are associated with poor prognosis in patients as mediators of tumor cell migration which may facilitate interaction and intravasation into lymphatics to promote tumor cell dissemination. Of particular interest is the RNASeq analysis of the lymphatic endothelial cells after exposure to TGFβ; this unique data set, when made publicly available, will provide a valuable resource to the research community and may reveal additional pathways important for lymphatic remodeling and metastatic spread through the lymphatics.
In the article presented by Woodward and colleagues, the contributions of diet and the primary function of the mammary gland, lactation, are investigated for potential roles in inflammatory breast cancer (IBC). This highly aggressive subtype of breast cancer involves invasion of skin lymphatics by tumor cell emboli and links to obesity and breastfeeding have previously been proposed as contributing to the unique biology of IBC. The study makes use of in vivo imaging of lymphatic pulsing in mice to investigate how high fat diet (HFD) and duration of lactation modulate lymphatic changes in a model of IBC. Their results suggest that HFD drives mammary lymphatic function in a manner that is independent of duration of lactation as well as parity. Furthermore, they identify a correlation of monocyte-derived cells in the tumor microenvironment with HFD. Since a normal role for lymphatics is the transport of lipids, these findings may also suggest that a systemic excess of fats may modulate lymphatic function in the mammary gland.
Finally, the manuscript by Singhal and colleagues utilizes lymphatic imaging in the form of preoperative lymphography to determine linear versus non-linear patterns of lymphatics in the upper extremities of breast cancer patients. Their results identify not only risk factors for development of non-linear patterns, but also suggest that non-linear patterns are associated with a higher risk for lymphedema after axillary lymph node dissection. For breast cancer survivors, lymphedema can be a lifelong condition that severely impedes quality of life, highlighting the importance of the outcome of these findings which is prophylactic prescription of compression sleeves for patients with non-linear patterns of lymphatics. This clinically relevant discovery further highlights the importance of understanding tissue draining lymphatic remodeling for both developmental biology and organ functions as well as for tumor biology and patient care.
In conclusion, this collection of articles highlights the wide variety of aspects by which the lymphatics play important roles in normal physiology and cancer and creates new foundations for additional investigations and discoveries to further improve our understanding and management of lymphatics in pathologies.

Acknowledgements

The authors wish to thank Erika Ginsburg for all her help with bringing this issue together and Petra Dahms for the cover art.

Declarations

Competing Interests

E.S. is an Editorial Board Member for the Journal of Mammary Gland Biology and Neoplasia.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Gynäkologie

Kombi-Abonnement

Mit e.Med Gynäkologie erhalten Sie Zugang zu CME-Fortbildungen der beiden Fachgebiete, den Premium-Inhalten der Fachzeitschriften, inklusive einer gedruckten gynäkologischen oder urologischen Zeitschrift Ihrer Wahl.

Literatur
1.
Zurück zum Zitat Mehrara BJ, Radtke AJ, Randolph GJ, Wachter BT, Greenwel P, Rovira. II. The emerging importance of lymphatics in health and disease: an NIH workshop report. J Clin Invest 2023; 133. Mehrara BJ, Radtke AJ, Randolph GJ, Wachter BT, Greenwel P, Rovira. II. The emerging importance of lymphatics in health and disease: an NIH workshop report. J Clin Invest 2023; 133.
3.
Zurück zum Zitat Kinney JR, Friedman R, Kim E, Tillotson E, Shillue K, Lee BT, Singhal D. Non-linear lymphatic anatomy in breast Cancer patients prior to Axillary Lymph Node Dissection: a risk factor for Lymphedema Development. J Mammary Gland Biol Neoplasia. 2023;28:20.CrossRefPubMedPubMedCentral Kinney JR, Friedman R, Kim E, Tillotson E, Shillue K, Lee BT, Singhal D. Non-linear lymphatic anatomy in breast Cancer patients prior to Axillary Lymph Node Dissection: a risk factor for Lymphedema Development. J Mammary Gland Biol Neoplasia. 2023;28:20.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Balema W, Morton J, Larson RA, Li L, Velasquez FC, Fowlkes NW, et al. High-fat diet, but not duration of lactation, increases mammary gland lymphatic vessel function and subsequent growth of inflammatory breast cancer cells. J Mammary Gland Biol Neoplasia. 2023;28:21.CrossRefPubMedPubMedCentral Balema W, Morton J, Larson RA, Li L, Velasquez FC, Fowlkes NW, et al. High-fat diet, but not duration of lactation, increases mammary gland lymphatic vessel function and subsequent growth of inflammatory breast cancer cells. J Mammary Gland Biol Neoplasia. 2023;28:21.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Giotopoulou N, Shi W, Parniewska MM, Sun W, Fuxe J. TGFss1 stimulates lymphatic endothelial cells to produce IL7 and IL15, which Act as Chemotactic factors for breast Cancer cells with Mesenchymal properties. J Mammary Gland Biol Neoplasia. 2023;28:25.CrossRefPubMedPubMedCentral Giotopoulou N, Shi W, Parniewska MM, Sun W, Fuxe J. TGFss1 stimulates lymphatic endothelial cells to produce IL7 and IL15, which Act as Chemotactic factors for breast Cancer cells with Mesenchymal properties. J Mammary Gland Biol Neoplasia. 2023;28:25.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Dahms P, Lyons TR. Toward characterizing lymphatic vasculature in the mammary gland during Normal Development and Tumor-Associated Remodeling. J Mammary Gland Biol Neoplasia. 2024;29:1.CrossRefPubMedPubMedCentral Dahms P, Lyons TR. Toward characterizing lymphatic vasculature in the mammary gland during Normal Development and Tumor-Associated Remodeling. J Mammary Gland Biol Neoplasia. 2024;29:1.CrossRefPubMedPubMedCentral
Metadaten
Titel
The Lymphatic System in Mammary Gland Biology and Breast Cancer
verfasst von
Traci R. Lyons
Esta Sterneck
Publikationsdatum
01.12.2024
Verlag
Springer US
Erschienen in
Journal of Mammary Gland Biology and Neoplasia / Ausgabe 1/2024
Print ISSN: 1083-3021
Elektronische ISSN: 1573-7039
DOI
https://doi.org/10.1007/s10911-024-09558-0

Weitere Artikel der Ausgabe 1/2024

Journal of Mammary Gland Biology and Neoplasia 1/2024 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.